DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Tebbutt NC. et al.
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study.
J Clin Oncol 2010;
28: 3191-3198
We do not assume any responsibility for the contents of the web pages of other providers.